Hantavirus Cardiopulmonary Syndrome and Diffuse Alveolar Hemorrhage in the Era of COVID-19 [PDF]
Case Reports in Infectious Diseases, 2021 Hantavirus Cardiopulmonary Syndrome (HCPS) can occur after infection with Hantavirus which can occur by inhaling aerosolized rodent urine, feces, and saliva contaminated with the virus.
Khizar Hamid +5 more
doaj +5 more sources
Hantavirus Cardiopulmonary Syndrome in Canada [PDF]
Emerging Infectious Diseases, 2020 Hantavirus cardiopulmonary syndrome (HCPS) is a severe respiratory disease caused by Sin Nombre virus in North America (SNV). As of January 1, 2020, SNV has caused 143 laboratory-confirmed cases of HCPS in Canada.
Bryce M. Warner +12 more
doaj +5 more sources
Bayou Hantavirus Cardiopulmonary Syndrome, Louisiana, USA, 2022–2023 [PDF]
Emerging Infectious DiseasesDuring 2020–2023, we sequenced Bayou virus from 2 patients in Louisiana, USA, with hantavirus cardiopulmonary syndrome. Direct virus sequencing demonstrated an inferred evolutionary relationship to previous cases.
Emma Ortega +10 more
doaj +4 more sources
Hantavirus Cardiopulmonary syndrome: Another Reason to Avoid Mice [PDF]
Journal of Investigative Medicine High Impact Case ReportsHantavirus cardiopulmonary syndrome is a severe illness transmitted by rodent excretions. We describe a case of a 24-year-old man who presented to the emergency department with cough, shortness of breath, chills, myalgias, nausea, and diarrhea.
Mark Kennedy MD +2 more
doaj +4 more sources
Journal of Global Infectious Diseases, 2018 Among hantaviruses (HTNV), 22 are known as pathogenic for humans. HTNV can cause two clinical entities: hemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary syndrome or hantavirus cardiopulmonary syndrome (HCPS).
Shemsedin Dreshaj +5 more
doaj +4 more sources
Differential Regulation of PAI-1 in Hantavirus Cardiopulmonary Syndrome and Hemorrhagic Fever With Renal Syndrome. [PDF]
Open Forum Infect Dis, 2018 We analyzed the levels of circulating tissue plasminogen activator (tPA) and plasminogen activator inhibitor (PAI)-1 in acute hantavirus cardiopulmonary syndrome (HCPS) and hemorrhagic fever with renal syndrome (HFRS).
Bellomo C +8 more
europepmc +8 more sources
Potential geographic distribution of hantavirus reservoirs in Brazil. [PDF]
PLoS ONE, 2013 Hantavirus cardiopulmonary syndrome is an emerging zoonosis in Brazil. Human infections occur via inhalation of aerosolized viral particles from excreta of infected wild rodents.
Stefan Vilges de Oliveira +3 more
doaj +5 more sources
Platelet Count in Patients with Mild Disease at Admission is Associated with Progression to Severe Hantavirus Cardiopulmonary Syndrome [PDF]
Viruses, 2019 Background: Hantavirus cardiopulmonary syndrome (HCPS) has a mortality up to 35–40% and its treatment is mainly supportive. A variable to predict progression from mild to severe disease is unavailable. This study was performed in patients with documented
René López +14 more
doaj +2 more sources
Therapeutic Efficacy of Human Monoclonal Antibodies against Andes Virus Infection in Syrian Hamsters [PDF]
Emerging Infectious Diseases, 2021 Andes virus, an orthohantavirus endemic to South America, causes severe hantavirus cardiopulmonary syndrome associated with human-to-human transmission. No approved treatments or vaccines against this virus are available.
Brandi N. Williamson +5 more
doaj +3 more sources
Clinical and anatomopathological aspects of patients with hantavirus cardiopulmonary syndrome in Uberaba, Minas Gerais, Brazil. [PDF]
Rev Inst Med Trop Sao Paulo, 2019 The hantavirus cardiopulmonary syndrome is considered an emerging disease in the Americas. Since 1993, thousands of cases have been reported from different countries, but mainly from Brazil.
Santos JPVD +3 more
europepmc +4 more sources